D.R. Horton (NYSE:DHI) Given "Underperform" Rating at Wedbus

Wedbush restated their underperform rating on shares of D.R. Horton (NYSE:DHI – Free Report) in a research report sent to investors on Thursday, Benzinga reports. They currently have a $130.00 price objective on the construction company’s stock. A number of other equities research analysts have also recently commented on the company. Citigroup raised their price […]

Related Keywords

Canada , United States , Barbarak Allen , Davidv Auld , , Goldman Sachs Group , Rise Advisors , Barclays , Royal Bank , Citigroup , Dr Horton Company Profile , Fairfield Bush , Riverview Trust Co , Dr Horton Inc , Mascoma Wealth Management , Free Report , Moderate Buy , Get Free Report , Director Barbara , Street Markets , Wealth Management , South Central , Dr Horton , Nyse Dhi , Dhi , Construction , 23331a10 , Reiterated Rating , Wedbush ,